Accelerated Stem Cell Senescence in Heart Failure
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-001031
Sponsor Protocol Number: 16-001031
About this study
The purpose of this study is to study circulating progenitor cells in human subjects with heart failure and before and after LVAD therapy.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Age 18 years or greater
- Willing and able to sign informed consent
- Falls into one of the following three categories:
- Normal control
- Non-ischemic and ischemic cardiomyopathy with chronic but stable heart failure (NYHA Class II-III) too well for left ventricular assist device (LVAD) implant
- Advanced non-ischemic and ischemic cardiomyopathy with scheduled LVAD placement and referred for pre-implant right heart catheterization
Exclusion Criteria:
- Known hematologic malignancy which would confound interpretation of hematopoietic progenitor cell counts
- Presence amyloid or other infiltrative heart disease.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Barry Boilson, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available